Table 3.
The main finding about the role of ILC2s in atopic dermatitis.
| Authors | Year | Study Characteristics |
|---|---|---|
| Nishikawa et al. [67] | 2021 | A mouse model using transgenic binary mice that are constitutively deficient in conventional dendritic cells (cDCs) demonstrated that congenital cDCs deficiency not only exacerbated atopic dermatitis (AD)-related inflammation but also resulted in immune alterations as the composition and function of the cells increased granulocytes and group 2 innate lymphoid cells (ILC2s). |
| Früh et al. [66] | 2020 | In a canine model, levated frequencies and numbers of T-helper 2 cells but not ILC2s in peripheral blood were associated with chronic canine atopy. |
| Imai et al. [78] | 2019 | In a mouse model, ILC2 cells were depleted in IL33tg mice via bone marrow transplantation; in these mice, the development of inflammation was almost completely suppressed, demonstrating the central role of ILC2s in immune processes. |
| Salimi et al. [70] | 2013 | The binding of E-cadherin to human ILC2s dramatically inhibited interleukin (IL)-5 and IL-13 release. In the absence of E-cadherin, which is characteristic of filaggrin insufficiency and feature of AD, ILC2s resulted in increased production of type 2 cytokines. |
| Salimi et al. [74] | 2015 | The expression of NKp30 ILC2s ex vivo and on cultured ILC2s and the interaction with its ligand B7-H6 induced the production of type 2 cytokines in AD. |
| Baek et al. [85] | 2017 | In a mouse model, immune tolerance was induced by oral administration of ovalbumin with subsequent epicutaneous sensitization by repeated application of ovalbumin. The induction of oral tolerance resulted in a reduction in the inflammatory response through the inhibition of ILC2 levels. |
| Perrone Sibilia et al. [84] | 2019 | Chronic infection with Toxoplasma gondii appeared to prevent the development of atopic dermatitis through a reduced susceptibility that appeared to result from changes in the type II innate immune response, with reductions in IL-4, IL-5, and ILC2s. |
| Lee et al. [82] | 2021 | Celastrol decreased the levels of thymic stromal lymphopoietin (TSLP), ILC2s, and T-helper 2-cytokines in AD lesions of house dust mite-stimulated NC/Nga mice. |
| Mashiko et al. [68] | 2017 | AD lesional skin, but not psoriasis skin, was infiltrated by increased numbers of basophils, which produced IL-4,T-helper 2 cells and ILC2s. |
| Schwartz et al. [79] | 2019 | ILC2 deficiency did not improve AD in Flgft/ft mice, which was also independent of IL-4, IL-5, IL-9, IL-13, IL-17A, and IL-22, but required the signaling of IL-1β and IL-1R1, which therefore, also play a fundamental role in the development of inflammation. |
| Natsume et al. [83] | 2020 | A study comparing the anti-itch effect of xanthophyll with tacrolimus observed that the former significantly reduced symptoms compared to the latter through the presence of ILCreg suppressing the immune response. |
| Hardman et al. [73] | 2017 | In a human AD-based model, TSLP-induced ILC2s expressed Cluster of Differentiation 1a (CD1a), which, in turn, activated TH lymphocytes. In addition, ILC2s presented endogenous lipid antigens to CD1a-reactive T cells. |